Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis
- PMID: 28606962
- DOI: 10.1136/annrheumdis-2016-210792
Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis
Abstract
Background: Giant-cell arteritis (GCA) is an inflammatory disease of large/medium-sized arteries, frequently involving the temporal arteries (TA). Inflammation-induced vascular remodelling leads to vaso-occlusive events. Circulating endothelin-1 (ET-1) is increased in patients with GCA with ischaemic complications suggesting a role for ET-1 in vascular occlusion beyond its vasoactive function.
Objective: To investigate whether ET-1 induces a migratory myofibroblastic phenotype in human TA-derived vascular smooth muscle cells (VSMC) leading to intimal hyperplasia and vascular occlusion in GCA.
Methods and results: Immunofluorescence/confocal microscopy showed increased ET-1 expression in GCA lesions compared with control arteries. In inflamed arteries, ET-1 was predominantly expressed by infiltrating mononuclear cells whereas ET receptors, particularly ET-1 receptor B (ETBR), were expressed by both mononuclear cells and VSMC. ET-1 increased TA-derived VSMC migration in vitro and α-smooth muscle actin (αSMA) expression and migration from the media to the intima in cultured TA explants. ET-1 promoted VSMC motility by increasing activation of focal adhesion kinase (FAK), a crucial molecule in the turnover of focal adhesions during cell migration. FAK activation resulted in Y397 autophosphorylation creating binding sites for Src kinases and the p85 subunit of PI3kinases which, upon ET-1 exposure, colocalised with FAK at the focal adhesions of migrating VSMC. Accordingly, FAK or PI3K inhibition abrogated ET-1-induced migration in vitro. Consistently, ET-1 receptor A and ETBR antagonists reduced αSMA expression and delayed VSMC outgrowth from cultured GCA-involved artery explants.
Conclusions: ET-1 is upregulated in GCA lesions and, by promoting VSMC migration towards the intimal layer, may contribute to intimal hyperplasia and vascular occlusion in GCA.
Keywords: 5-bisphosphate 3-kinase (PI3K); Giant-cell arteritis; Src kinase; cell migration; endothelin; extracellular signal -regulated kinase; focal adhesion kinase; matrix metaloproteinases. Heterotrimeric G proteins.; myofibroblast; phosphatidylinositol-4; vascular inflammation; vascularremodelling.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Identification of microRNAs and their target gene networks implicated in arterial wall remodelling in giant cell arteritis.Rheumatology (Oxford). 2020 Nov 1;59(11):3540-3552. doi: 10.1093/rheumatology/keaa204. Rheumatology (Oxford). 2020. PMID: 32594153
-
Increased tissue endothelin-1 and endothelin-B receptor expression in temporal arteries from patients with giant cell arteritis.Ophthalmology. 2010 Mar;117(3):628-36. doi: 10.1016/j.ophtha.2009.07.043. Epub 2009 Dec 24. Ophthalmology. 2010. PMID: 20036012
-
Epidermal growth factor receptor transactivation by endogenous vasoactive peptides contributes to hyperproliferation of vascular smooth muscle cells of SHR.Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1959-67. doi: 10.1152/ajpheart.00526.2010. Epub 2010 Sep 17. Am J Physiol Heart Circ Physiol. 2010. PMID: 20852045
-
Molecular analysis of vascular smooth muscle cells from patients with giant cell arteritis: Targeting endothelin-1 receptor to control proliferation.Autoimmun Rev. 2017 Apr;16(4):398-406. doi: 10.1016/j.autrev.2017.02.006. Epub 2017 Feb 14. Autoimmun Rev. 2017. PMID: 28232168 Review.
-
Current state of epigenetics in giant cell arteritis: Focus on microRNA dysregulation.Autoimmun Rev. 2025 Feb 28;24(3):103739. doi: 10.1016/j.autrev.2024.103739. Epub 2024 Dec 26. Autoimmun Rev. 2025. PMID: 39732382 Review.
Cited by
-
Current Insights into Tissue Injury of Giant Cell Arteritis: From Acute Inflammatory Responses towards Inappropriate Tissue Remodeling.Cells. 2024 Feb 29;13(5):430. doi: 10.3390/cells13050430. Cells. 2024. PMID: 38474394 Free PMC article. Review.
-
Fluid Shear Stress-Regulated Vascular Remodeling: Past, Present, and Future.Arterioscler Thromb Vasc Biol. 2025 Jun;45(6):882-900. doi: 10.1161/ATVBAHA.125.322557. Epub 2025 Apr 10. Arterioscler Thromb Vasc Biol. 2025. PMID: 40207366 Review.
-
An immunohistochemical analysis of folate receptor beta expression and distribution in giant cell arteritis - a pilot study.Am J Clin Exp Immunol. 2017 Dec 20;6(6):107-114. eCollection 2017. Am J Clin Exp Immunol. 2017. PMID: 29348986 Free PMC article.
-
Giant Cell Arteritis: Advances in Understanding Pathogenesis and Implications for Clinical Practice.Cells. 2024 Jan 31;13(3):267. doi: 10.3390/cells13030267. Cells. 2024. PMID: 38334659 Free PMC article. Review.
-
Vascular disease persistence in giant cell arteritis: are stromal cells neglected?Ann Rheum Dis. 2024 Aug 27;83(9):1100-1109. doi: 10.1136/ard-2023-225270. Ann Rheum Dis. 2024. PMID: 38684323 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous